10-Q: Pinnacle Financial Reports Strong Q3, YTD 2025 Earnings

Pinnacle Financial Partners delivered robust financial results for Q3 and YTD 2025, marked by significant increases in net income, EPS, and strategic merger progress with Synovus.

Summary

• Net income available to common shareholders increased to $169.3 million for Q3 2025, up 18.5% from $142.9 million in Q3 2024, and to $460.7 million for YTD 2025, up 47.5% from $312.4 million in YTD 2024.
• Diluted net income per common share rose to $2.19 for Q3 2025, an 17.7% increase from $1.86 in Q3 2024, and to $5.96 for YTD 2025, up 46.1% from $4.08 in YTD 2024.
• Total loans grew by 6.9% to $37.9 billion at September 30, 2025, from $35.5 billion at December 31, 2024.
• Total deposits increased by 6.7% to $45.7 billion at September 30, 2025, from $42.8 billion at December 31, 2024, with noninterest-bearing deposits up 9.6% to $9.0 billion.
• Net interest income increased by 12.9% to $396.9 million for Q3 2025 and by 13.9% to $1.14 billion for YTD 2025.
• Net interest margin expanded to 3.26% for Q3 2025 (from 3.22% in Q3 2024) and to 3.24% for YTD 2025 (from 3.14% in YTD 2024).
• Noninterest income surged by 28.4% to $147.9 million for Q3 2025 and by 43.2% to $371.8 million for YTD 2025, largely driven by a more than 100% increase in income from the equity method investment in BHG for Q3 2025.
• The efficiency ratio improved to 57.2% for YTD 2025, down from 61.3% in YTD 2024.
• Provision for credit losses was $31.9 million for Q3 2025 and $73.1 million for YTD 2025, with net charge-offs of $16.8 million and $49.5 million, respectively.
• Nonperforming assets increased slightly to $154.9 million at September 30, 2025, from $149.1 million at December 31, 2024.
• Pinnacle Financial entered into an Agreement and Plan of Merger with Synovus Financial Corp. on July 24, 2025, which was unanimously approved by the boards of directors of all involved parties.

Sentiment

Score: 8

Explanation: The company demonstrates robust financial performance with significant increases in net income, EPS, net interest income, and noninterest income, driven by strong loan and deposit growth and an improved efficiency ratio. The strategic merger with Synovus, while presenting integration risks, is positioned as a strategic growth opportunity, and capital and liquidity remain strong and exceed regulatory requirements. The overall outlook is positive, reflecting strong operational execution and strategic positioning.

Positives

• Net income available to common shareholders increased by 18.5% for Q3 2025 and 47.5% for YTD 2025.
• Diluted EPS grew by 17.7% for Q3 2025 and 46.1% for YTD 2025.
• Strong loan growth of 6.9% and deposit growth of 6.7% since December 31, 2024.
• Noninterest-bearing deposits increased by 9.6%, indicating a favorable shift in funding mix.
• Net interest income increased significantly, up 12.9% for Q3 2025 and 13.9% for YTD 2025.
• Net interest margin expanded for both the three and nine months ended September 30, 2025, reflecting a declining cost of funds.
• Noninterest income saw substantial growth, up 28.4% for Q3 2025 and 43.2% for YTD 2025, primarily due to strong performance from the BHG equity method investment and wealth management groups.
• The efficiency ratio improved to 57.2% for YTD 2025, indicating better operational cost management.
• Net charge-offs decreased to $16.8 million for Q3 2025 and $49.5 million for YTD 2025, compared to prior year periods.
• Capital ratios for both Pinnacle Financial and Pinnacle Bank exceeded all regulatory minimums and 'well-capitalized' thresholds.

Negatives

• Provision for credit losses increased to $31.9 million for Q3 2025 from $26.3 million in Q3 2024, partly due to increased off-balance sheet reserves.
• Investment losses on sales of securities, net, were $12.5 million for YTD 2025, although lower than $72.1 million in YTD 2024.
• Gains on mortgage loans sold, net, decreased by 30.8% for Q3 2025 and 28.3% for YTD 2025 due to higher mortgage interest rates.
• Nonperforming assets increased slightly to $154.9 million at September 30, 2025, from $149.1 million at December 31, 2024.
• Merger-related expenses of $7.7 million were incurred during Q3 and YTD 2025 due to the proposed Synovus merger.
• Other real estate owned (OREO) increased to $5.1 million at September 30, 2025, from $1.3 million at December 31, 2024.

Risks

• Deterioration in the financial condition of borrowers, including from persistent elevated interest rates, inflation, and challenging economic conditions, could lead to increased loan losses.
• Fluctuations or differences in interest rates could negatively impact net interest margin, especially if deposit rates cannot be matched with changes in the short-term rate environment.
• Adverse conditions in the national or local economies, particularly in commercial and residential real estate markets, could affect asset quality.
• The proposed merger with Synovus carries risks including the inability to fully realize cost savings and synergies, integration difficulties, disruption to business operations, failure to obtain necessary shareholder and regulatory approvals, and significant transaction costs.
• Governmental entities may impose conditions, limitations, or divestitures as a condition for regulatory approvals of the merger, which could adversely affect the combined company.
• Uncertainty about the effect of the proposed merger on employees, customers, and business partners could lead to loss of key employees, customer attrition, and revenue loss.
• The combined company may be subject to additional regulatory requirements due to its expanded size and operations post-merger.
• Inability to grow and retain low-cost core deposits and retain large, uninsured deposits, especially during financial services sector uncertainty, could negatively impact liquidity and net interest margin.
• Vulnerability of network and online banking portals to unauthorized access, cyberattacks, human error, and natural disasters poses security risks.
• Changes in state and federal legislation, regulations, or policies applicable to banks and financial service providers could increase compliance and operational costs.
• Risks associated with being a minority investor in BHG, including the possibility that majority owners decide to sell the company or their ownership interests.

Future Outlook

Management expects total salary and benefit expenses for 2025 to increase due to continued hiring of experienced bankers and market extensions. Marketing and business development costs are also anticipated to rise modestly. The company is evaluating the impact of the One Big Beautiful Bill Act (OBBBA) tax reform on its effective tax rate and deferred tax assets in 2025 and future periods. Bankers Healthcare Group (BHG) is expected to complete additional securitizations or establish other borrowing facilities to support loan retention.

Management Comments

• We believe that cash and equity incentives are a valuable tool in motivating an associate base that is focused on providing our clients effective financial advice and increasing shareholder value.
• We expect total salary and benefit expenses for the year ended 2025 to increase when compared to the comparable period in 2024 as we continue our focus on hiring experienced bankers in all of our markets.
• We believe that equity incentives provide a vehicle for all associates to become meaningful shareholders of Pinnacle Financial over an extended period of time and create a shareholder-centric culture throughout our organization.
• At September 30, 2025, we anticipated that payouts under our annual cash incentive plan would be at maximum payout levels.
• We believe we have adequate liquidity to meet all known contractual obligations and unfunded commitments, including loan commitments and reasonable borrower, depositor and creditor requirements over the next twelve months and that we will have adequate liquidity to meet our obligations over a longer-term as well.

Industry Context

The company operates in a competitive financial services landscape, facing pricing pressures and a challenging deposit gathering environment. Its equity method investment, Bankers Healthcare Group (BHG), adjusts its loan sale and retention strategies based on interest rates and demand from institutional buyers. The broader banking industry may face future regulatory changes, such as the potential imposition of Basel III Liquidity Coverage Ratio (LCR) guidelines on smaller banks, which could impact net interest margins.

Comparison to Industry Standards

• Pinnacle Bank's construction and land development loans as a percentage of total risk-based capital were 59.6% at September 30, 2025, well within the regulatory guideline of less than 100%.
• Non-owner occupied commercial real estate and multifamily loans (including construction and land development loans) as a percentage of total risk-based capital were 218.1% at September 30, 2025, remaining below the regulatory guideline of less than 300%.
• The company's capital ratios (Total, Tier 1, Common Equity Tier 1, and Tier 1 Leverage) for both Pinnacle Financial and Pinnacle Bank exceeded all regulatory minimum capital requirements and those necessary to be considered 'well-capitalized' under applicable federal regulations at September 30, 2025 and December 31, 2024.

Management Changes

Corporate Governance

Legal Proceedings

• There are no material pending legal proceedings to which Pinnacle Financial or a subsidiary is a party or of which any of their property is the subject.

Related Party Transactions

• Loans and other extensions of credit to current directors, executive officers, and their related interests amounted to approximately $54.1 million at September 30, 2025, with $47.5 million drawn upon. All such loans were performing in accordance with contractual terms.
• Pinnacle Bank holds a 49% equity method investment in Bankers Healthcare Group, LLC (BHG).
• Pinnacle Bank held $117.0 million of BHG joint venture program loans at September 30, 2025, purchased from BHG at par, with proportionate credit risk sharing.

Stakeholder Impact

• Shareholders: Potential for increased value from merger synergies, but also risks of integration difficulties, dilution from new stock issuance, and potential stock price decline if the merger fails. Continued common and preferred dividends are expected.
• Employees: Uncertainty about future roles with the combined company, potential for retention challenges, but also benefits from an increased associate base, annual merit increases, and cash/equity incentive accruals.
• Customers: Potential for enhanced services and a strengthened market position from the combined entity, but also possible disruption during merger integration and risk of customer loss.
• Regulators: Increased oversight due to the merger's size and complexity, with potential for additional regulatory requirements on the combined company.
• Suppliers/Business Partners: Reputational risk and potential reactions to the proposed merger.

Next Steps

• Obtain the Requisite Pinnacle Vote and Requisite Synovus Vote from shareholders for the proposed merger.
• Secure required regulatory approvals for the merger from the Board of Governors of the Federal Reserve System, the Tennessee Department of Financial Institutions, and the Georgia Department of Banking and Finance.
• Ensure the effectiveness of the registration statement on Form S-4 for the Newco Common Stock and Newco Preferred Stock to be issued in the merger.
• Complete the merger with Synovus and the subsequent bank merger, with Newco continuing as the surviving corporation and Pinnacle Bank as the surviving bank.
• Integrate the respective businesses and operations of Pinnacle Financial and Synovus.
• Continue evaluating the impact of the One Big Beautiful Bill Act (OBBBA) tax reform on financial results.
• Maintain focus on hiring experienced bankers and expanding market presence.
• Implement new and enhanced deposit gathering initiatives.
• Monitor and manage interest rate sensitivity and liquidity risk through various strategies.
• Bankers Healthcare Group (BHG) is anticipated to complete additional securitizations or establish other borrowing facilities.
• Continue the share repurchase program for up to $125.0 million of common stock through March 31, 2026.
• Pay the declared $0.24 per share quarterly cash dividend to common shareholders on November 28, 2025.
• Pay the declared $16.88 per share (or $0.422 per depositary share) quarterly dividend on Series B Preferred Stock on December 1, 2025.

Key Dates

Recommendation

The company demonstrates robust financial performance with significant increases in net income, EPS, net interest income, and noninterest income, driven by strong loan and deposit growth and an improved efficiency ratio. The strategic merger with Synovus, while carrying integration risks, presents substantial long-term growth and synergy potential, positioning the combined entity for a strengthened market presence. Capital and liquidity remain well above regulatory requirements, indicating financial stability. The positive trends in core banking operations, coupled with the strategic expansion, suggest a compelling investment opportunity despite the inherent risks of a large-scale merger.

Keywords

Pinnacle Financial Partners, PNFP, Banking, Financial Services, Commercial Banking, Wealth Management, Investment Services, Insurance, Trust Services, Mortgage Lending, SEC Filing, 10-Q, Quarterly Report, Earnings, Net Interest Income, Deposits, Loans, Credit Quality, Allowance for Credit Losses, BHG, Bankers Healthcare Group, Synovus Merger, Merger Agreement, Capital Ratios, Liquidity, Interest Rate Risk, Share Repurchase